Co-Authors
This is a "connection" page, showing publications co-authored by Bryan Greenhouse and Isabel Rodriguez-Barraquer.
Connection Strength
1.169
-
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. Sci Adv. 2021 Jul; 7(31).
Score: 0.240
-
Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records. Nat Commun. 2021 06 11; 12(1):3566.
Score: 0.238
-
Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased? J Infect Dis. 2020 11 09; 222(11):1772-1775.
Score: 0.228
-
Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa531.
Score: 0.228
-
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021 08 10; 36(6):109518.
Score: 0.060
-
Comparison of infection control strategies to reduce COVID-19 outbreaks in homeless shelters in the United States: a simulation study. BMC Med. 2021 05 07; 19(1):116.
Score: 0.059
-
Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study. Lancet Infect Dis. 2021 07; 21(7):929-938.
Score: 0.058
-
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells. 2021 02 13; 10(2).
Score: 0.058